Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

Results 91-100 of 113
Item hits:
Issue DateTitleAuthor(s)
5-Apr-2019Pirfenidone treatment in individuals with idiopathic pulmonary fibrosis: Impact of timing of treatment initiationMaher, TM; Lancaster, LH; Jouneau, S; Morrison, L; Lederer, DJ, et al
24-Jul-2019Overlap of genetic risk between interstitial lung abnormalities and idiopathic pulmonary fibrosis.Hobbs, BD; Putman, RK; Araki, T; Nishino, M; Gudmundsson, G, et al
4-Jun-2019Variable utility of mosaic attenuation to distinguish fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosisBarnett, J; Molyneaux, PL; Rawal, B; Abdullah, R; Hare, SS, et al
20-May-2019Nintedanib for systemic sclerosis-associated interstitial lung diseaseDistler, O; Highland, KB; Gahlemann, M; Azuma, A; Fischer, A, et al
15-Sep-2018Predicting outcomes in idiopathic pulmonary fibrosis using automated CT analysisJacob, J; Bartholmai, BJ; Rajagopalan, S; Van Moorsel, CHM; Van Es, HW, et al
1-May-2018Incidence, prevalence, and survival of patients with idiopathic pulmonary fibrosis in the UKStrongman, H; Kausar, I; Maher, TM
17-Jul-2019Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled studyMaher, TM; Stowasser, S; Nishioka, Y; White, ES; Cottin, V, et al
1-Mar-2019Influence of idiopathic pulmonary fibrosis progression on healthcare resource useDiamantopoulos, A; Maher, TM; Schoof, N; Esser, D; LeReun, C
26-Jun-2019Diagnostic likelihood thresholds that define a working diagnosis of idiopathic pulmonary fibrosisWalsh, SLF; Lederer, DJ; Ryerson, CJ; Kolb, M; Maher, TM, et al
20-Jun-2019Kings brief interstitial lung disease questionnaire: Responsiveness and minimum clinically important differenceNolan, CM; Birring, SS; Maddocks, M; Maher, TM; Patel, S, et al